AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyNot reportedPeer review unconfirmed
Case Report of a 16-Year-Old Boy Diagnosed with Multiple Sclerosis
A 16-year-old boy exhibited symptoms including headaches and right arm weakness and was diagnosed with MS after meeting the 2024 McDonald criteria, which included MRI findings of lesions and presence of central vein sign (CVS). He was treated with IV steroids, oral steroids, and ocrelizumab.
- Tags
- #MSResearch
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
This case highlights the importance of recognizing MRI biomarkers like the central vein sign for the early diagnosis of MS in pediatric patients, potentially leading to timely treatment.
What this does not prove
Case reports cannot provide strong evidence for generalizable conclusions.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-01
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidencePearls & Oy-sters: Diagnosis of Pediatric Tumefactive Multiple Sclerosis With MRI Biomarkers. ↗DOI: 10.1212/wnl.0000000000218575
Supporting passages (5)
subjectsWe describe the case of a 16-year-old boy who presented with subacute onset of headaches, cognitive difficulties, dizziness, blurry vision, right arm weakness, numbness, and gait difficulty.
interventionThe patient was treated with IV steroids followed by oral steroids and then started on ocrelizumab.
findingsBased on the presence of typical symptoms, multiple enhancing and nonenhancing lesions in the periventricular and juxtacortical regions, and 6 CVS-positive lesions, the patient met 2024 McDonald criteria, and the diagnosis of MS was made.
publication datePublication date: 2026-10-01
limitationsTitle: Pearls & Oy-sters: Diagnosis of Pediatric Tumefactive Multiple Sclerosis With MRI Biomarkers.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.